Use of the Absorb bioresorbable vascular scaffold (BVS, Abbott Vascular) is associated with an increased risk of definite or probable scaffold thrombosis at 1 year and beyond, as well as increased ...
In patients with very long coronary lesions, use of Absorb BVS (Abbott Vascular) is associated with a high rate of TLF at 1 year, driven by MI and clinically driven TLR, according to a subanalysis ...
Southern Co. will absorb $1.1 billion in additional pre-tax costs for its Plant Vogtle nuclear expansion project, the company said in financial disclosures early today. Southern Co. will absorb $1.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback